Author
Listed:
- Mohammed Hoque
(Regeneron Pharmaceuticals, Inc.)
- John Benji Grigg
(Regeneron Pharmaceuticals, Inc.)
- Trudy Ramlall
(Regeneron Pharmaceuticals, Inc.)
- Jennifer Jones
(Regeneron Pharmaceuticals, Inc.)
- Luke L. McGoldrick
(Regeneron Pharmaceuticals, Inc.)
- John C. Lin
(Regeneron Pharmaceuticals, Inc.)
- William C. Olson
(Regeneron Pharmaceuticals, Inc.)
- Eric Smith
(Regeneron Pharmaceuticals, Inc.)
- Matthew C. Franklin
(Regeneron Pharmaceuticals, Inc.)
- Tong Zhang
(Regeneron Pharmaceuticals, Inc.)
- Kei Saotome
(Regeneron Pharmaceuticals, Inc.)
Abstract
The T-cell receptor (TCR)/CD3 complex plays an essential role in the immune response and is a key player in cancer immunotherapies. There are two classes of TCR/CD3 complexes, defined by their TCR chain usage (αβ or γδ). Recently reported structures have revealed the organization of the αβ TCR/CD3 complex, but similar studies regarding the γδ TCR/CD3 complex have lagged behind. Here, we report cryoelectron microscopy (cryoEM) structural analysis of two γδ TCRs, G115 (Vγ9 Vδ2) and 9C2 (Vγ5 Vδ1), in complex with CD3 subunits. Our results show that the overall subunit organization of the γδ TCR/CD3 complexes is similar to αβ TCRs. However, both γδ TCRs display highly mobile extracellular domains (ECDs), unlike αβ TCRs, which have TCR ECDs that are rigidly coupled to its transmembrane (TM) domains. We corroborate this finding in cells by demonstrating that a γδ T-cell specific antibody can bind a site that would be inaccessible in the more rigid αβ TCR/CD3 complex. Furthermore, we observed that the Vγ5 Vδ1 complex forms a TCR γ5 chain-mediated dimeric species whereby two TCR/CD3 complexes are assembled. Collectively, these data shed light on γδ TCR/CD3 complex formation and may aid the design of γδ TCR-based therapies.
Suggested Citation
Mohammed Hoque & John Benji Grigg & Trudy Ramlall & Jennifer Jones & Luke L. McGoldrick & John C. Lin & William C. Olson & Eric Smith & Matthew C. Franklin & Tong Zhang & Kei Saotome, 2025.
"Structural characterization of two γδ TCR/CD3 complexes,"
Nature Communications, Nature, vol. 16(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55467-5
DOI: 10.1038/s41467-024-55467-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55467-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.